Pre-Travel Vaccinations and Malaria Prophylaxis for International Travelers

Crossmark: check for updates

Authors

  • Androula Pavli Travel Medicine Office, Department for Interventions in Health-Care Facilities, Hellenic Center for Disease Control and Prevention, Athens, Greece
  • Helena C. Maltezou Travel Medicine Office, Department for Interventions in Health-Care Facilities, Hellenic Center for Disease Control and Prevention, Athens, Greece

DOI:

https://doi.org/10.17140/PHOJ-2-116

Keywords:

Pre-travel; Vaccination; Prophylaxis; Malaria; International traveler.

Abstract

International travel has increased dramatically the past decades, potentially posing health risks at the level of traveler and the level of public health. Vaccine-preventable diseases and malaria constitute a non-negligible proportion of imported infectious diseases to developed countries. This is a short review of pre-travel advice regarding vaccination and malaria prophylaxis for international travelers to developing countries. Vaccination and malaria prophylaxis depend on a risk-benefit analysis, weighting the risk of the disease against the risk of possible side effects of the vaccine or antimalarial agent. Recommendations for vaccination and malaria prophylaxis are based on the epidemiological situation at destination, travel’s (e.g., destination, purpose and duration of travel) and traveler’s (e.g., demographics, medical history and past vaccinations) characteristics. Recommendations of vaccination and malaria prophylaxis should be based on selective and individualized risk assessment. Public health authorities should increase awareness of travelers and health professionals for travel related health issues in order to prevent travel-associated vaccine-preventable diseases and malaria and promote safety both for the traveler as well as for the community.

References

United Nations World Tourism Organization. Annual Report. 2015. Web site. http://cf.cdn.unwto.org/sites/all/files/pdf/annu-al_report_2015_lr.pdf. Accessed December 13, 2016.

Boggild AK, Castelli F, Gautret P, et al. Vaccine preventable diseases in returned international travelers: Results from the Ge-oSentinel Surveillance Network. Vaccine. 2010; 28(46): 7389- 7395. doi: 10.1016/j.vaccine.2010.09.009

Centers for Disease Control and Prevention. Measles out-breaks. Web site. http://www.cdc.gov/measles/outbreaks.html. Accessed December 13, 2016.

Wilson ME, Weld LH, Boggild A, et al. Fever in returned trav-elers: Results from the GeoSentinel Surveillance Network. Clin Infect Dis. 2007; 44(12): 1560-1568. doi: 10.1086/518173

Lau S, Gherardin T. Travel vaccination. Aust Fam Physi-cian. 2007; 36(5): 304-311. Web site. http://search.proquest. com/openview/42f76ed02da0e1e6e6e963dcd101b04c/1?pq-origsite=gscholar&cbl=33668. Accessed December 13, 2016.

Virk A, Jong EC. Adult immunizations. In: Keystone JS, Kozarsky PE, Freedman DO, Nothdurft HD, Connor BA, eds. Travel Medicine. Elsevier: Mosby, Spain; 2004: 87-123.

Reiter P. Global warming and malaria: Knowing the horse before hitching the cart. Malar J. 2008; 7(Suppl 1): S3. doi: 10.1186/1475-2875-7-S1-S3

Sachs J, Malaney P. The economic and social burden of ma-laria. Nature. 2002; 415(6872): 680-685. doi: 10.1038./415680a

World Health Organization. World Malaria Report. 2016. Web site. http://apps.who.int/iris/bitstream/10665/252038/1/97892 41511711-eng.pdf?ua=1. Accessed December 13, 2016.

Mali S, Steele S, Slutsker L, Arguin PM. Centers for Disease Control and Prevention (CDC). Malaria surveillance-United States, 2006. MMWR Surveill Summ. 2008; 57(SS05): 24-39.

Romi R, Sabatinelli G, Majori G. Malaria epidemiological situation in Italy and evaluation of malaria incidence in Italian travelers. J Travel Med. 2001; 8(1): 6-11. doi: 10.2310/7060.2001.5140

Malaria. International Travel and Health. Web site. http:// www.who.int/ith/ITH2010chapter7.pdf. Accessed December 13, 2016.

Ehrhardt S. Malaria. In: Maltezou HC, Gikas A, eds. Tropi-cal and Emerging Infectious Diseases. Kerala, India: Research Signpost; 2010: 147-162.

Keystone JS, Steffen R, Kozarsky PE. Health advice for in-ternational traveler. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases: Principles, Pathogens, and Prac-tice. Philadelphia, USA: Churchill Livingstone Elsevier; 2006: 1400-1424.

World Health Organization. International Travel and Health. Web site. http://www.who.int/ith/chapters/ith2012en_chap6.pdf. Accessed December 13, 2016.

Centers for Disease Control and Prevention. Web site. http:// wwwnc.cdc.gov/travel/destinations/list.htm. Accessed Decem-ber 13, 2016.

Steffen R. Changing travel-related global epidemiology of hepatitis A. Am J Med. 2005; 118 (Suppl 10A): S46-S49. doi: 10.1016/j.amjmed.2005.07.016

Mutsch M, Spicher VM, Gut C, Steffen R. Hepatitis A virus infections in travelers, 1988-2004. Clin Infect Dis. 2006; 42(4): 490-497. doi: 10.1086/499816

Liu SJ, Sharapov U, Klevens M. Patient awareness of need for hepatitis a vaccination (prophylaxis) before internation-al travel. J Travel Med. 2015; 22(3): 174-178. doi: 10.1111/ jtm.12186

Pavli A, Spilioti A, Lymperi I, Katerelos P, Maltezou HC. Vaccinations for international travellers travelling from Greece. Travel Med Infect Dis. 2013; 11(4): 225-230. doi: 10.1016/j. tmaid.2012.11.007

Pavli A, Katerelos P, Smeti P, Maltezou HC. Meningococ-cal vaccination for international travellers from Greece visiting developing countries. Travel Med Infect Dis. 2016; 14(3): 261- 266. doi: 10.1016/j.tmaid.2016.03.001

Pavli A, Maltezou HC. Travel-acquired Japanese encepha-litis and vaccination considerations. J Infect Dev Ctries. 2015; 9(9): 917-924. doi: 10.3855/jidc.5108

Pavli A, Smeti P, Spilioti A, Vakali A, Katerelos P, Maltezou HC. Descriptive analysis of malaria prophylaxis for travelers from Greece visiting malaria-endemic countries. Travel Med In-fect Dis. 2011; 9(6): 284-288. doi: 10.1016/j.tmaid.2011.09.005

Schlagenhauf P, Petersen E. Malaria chemoprophylaxis: Strategies for risk groups. Clin Microbiol Rev. 2008; 21(3): 466- 472. doi: 10.1128/CMR.00059-07

Phillips-Howard PA, Radalowicz A, Mitchell J, Bradley DJ. Risk of malaria in British residents returning from ma-larious areas. BMJ. 1990; 300(6723): 499-503. doi: 10.1136/ bmj.300.6723.499

Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine com-pared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet. 1993; 341(8856): 1299-1303.

Overbosch D, Schilthuis H, Bienzle U, et al. Malarone Inter-national Study Team. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: Results from a randomized, double-blind study. Clin Infect Dis. 2001; 33(7): 1015-1021. doi: 10.1086/322694

Calleri G, Behrens RH, Bisoffi Z, et al. Variability in malaria prophylaxis prescribing across Europe: A Delphi method analy-sis. J Travel Med. 2008; 15(5): 294-301. doi: 10.1111/j.1708- 8305.2008.00226.x

Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006; 354(2): 119-130. doi: 10.1056/ NEJMoa051331

Schlagenhauf P, Petersen E. Standby emergency treatment of malaria in travelers: Experience to date and new develop-ments. Expert Rev Anti Infect Ther. 2012; 10(5): 537-546. doi: 10.1586/eri.12.42

Behrens RH, Bisoffi Z, Björkman A, et al. Malaria prophy-laxis policy for travellers from Europe to the Indian Subconti-nent. Malar J. 2006; 5: 7. doi: 10.1186/1475-2875-5-7

Gautret P, Schlagenhauf P, Gaudart J, et al. Multicenter Euro TravNet/GeoSentinel study of travel-related infectious diseas-es in Europe. Emerg Infect Dis. 2009; 15(11): 1783-1790. doi: 10.3201/eid1511.091147

Field V, Gautret P, Schlagenhauf P, et al. Travel and migra-tion associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis. 2010; 10: 330 doi: 10.1186/1471-2334-10-330

Fenner L, Weber R, Steffen R, Schlagenhauf P. Imported in-fectious disease and purpose of travel, Switzerland. Emerg Infect Dis. 2007; 13(2): 217-222. doi: 10.3201/eid1302.060847

Ericsson CD, Hatz C, Leder K, et al. Illness in travelers visit-ing friends and relatives: A review of the GeoSentinel Surveil-lance Network. Clin Infect Dis. 2006; 43(9): 1185-1193. doi: 10.1086/507893

Angell SY, Cetron MS. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med. 2005; 142(1): 67-72. doi: 10.7326/0003-4819-142-1-200501040- 00013

Angell SY, Behrens RH. Risk assessment and disease prevention in travelers visiting friends and relatives. Infect Dis Clin North Am. 2005; 19(1): 49-65. doi: 10.1016/j. idc.2004.11.001

Pavli A, Katerelos P, Pierroutsakos P, Maltezou HC. Pre-travel counselling in Greece for travelers visiting friends and relatives. Travel Med Infect Dis. 2009; 7(5): 312-315.

Published

2017-06-30

How to Cite

Androula Pavli, & Helena C. Maltezou. (2017). Pre-Travel Vaccinations and Malaria Prophylaxis for International Travelers. Public Health - Open Journal, 2(1), 21–25. https://doi.org/10.17140/PHOJ-2-116